Sanofi EUR500m 0% April 2019, EUR600m 0.625% April 2024, EUR700m 1.125% April 2028

Ross Lancaster

March 31, 2016 09:15 PM

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Bond Comments Corporate Bond Comments Corporate Bonds

RL

Ross Lancaster

Related articles

Corporate Bonds

Smurfit's 12 year bond takes big demand despite investors shunning duration

Long maturities continue to attract healthy oversubscriptions, but some investors don't see their value

Mike Turner, November 20, 2024
People News

Barclays hires from Deutsche to replace Shah on syndicate

Key role in Paris filled

Jon Hay, November 20, 2024
Syndicated Loans

Fitch hits Southern Water with third ratings downgrade this month

Moody's and S&P have also cut the UK water utility's ratings

Jennifer Law, November 19, 2024
Corporate Bonds

Abertis hybrid bucks diminishing return trend for structure

Toll road company tightens 50bp and sees ample demand

Mike Turner, November 19, 2024
Coben the Contrarian

Education in investment banks is unfit for purpose

The way banks do compliance training makes them riskier, not safer

Craig Coben, November 18, 2024
Corporate Bonds

Roquette debut hints that hybrids are a tough sell

Bigger book for senior tranche of debut, but borrower manages to increase size of deal

Mike Turner, November 18, 2024